$4.47 Billion is the total value of HHLR ADVISORS, LTD.'s 43 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 43.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BGNE | BEIGENE LTDsponsored adr | $550,084,000 | -6.1% | 4,437,953 | 0.0% | 12.30% | -24.6% | |
JD | Buy | JD COM INCspon adr cl a | $477,082,000 | +5.2% | 15,750,469 | +4.7% | 10.67% | -15.6% |
TAL | TAL EDUCATION GROUPsponsored ads | $434,738,000 | +5.6% | 11,410,453 | 0.0% | 9.72% | -15.2% | |
IQ | Buy | IQIYI INCsponsored ads | $299,632,000 | -0.2% | 14,510,018 | +15.5% | 6.70% | -19.9% |
CBPO | CHINA BIOLOGIC PRODS HLDGS I | $262,189,000 | +4.4% | 2,751,200 | 0.0% | 5.86% | -16.2% | |
BABA | ALIBABA GROUP HLDG LTDsponsored ads | $239,235,000 | -7.1% | 1,411,830 | 0.0% | 5.35% | -25.4% | |
FB | FACEBOOK INCcl a | $227,663,000 | +15.8% | 1,179,600 | 0.0% | 5.09% | -7.0% | |
EDU | Buy | NEW ORIENTAL ED & TECH GRP Ispon adr | $164,431,000 | +65150.4% | 1,702,534 | +60704.8% | 3.68% | +52428.6% |
PDD | Buy | PINDUODUO INCsponsored ads | $148,494,000 | +91.2% | 7,197,978 | +129.8% | 3.32% | +53.5% |
WUBA | New | 58 COM INCspon adr rep a | $146,767,000 | – | 2,360,742 | +100.0% | 3.28% | – |
SE | SEA LTDsponsored ads | $142,846,000 | +41.2% | 4,300,000 | 0.0% | 3.19% | +13.4% | |
BPMC | BLUEPRINT MEDICINES CORP | $141,355,000 | +17.8% | 1,498,516 | 0.0% | 3.16% | -5.4% | |
MDLZ | Sell | MONDELEZ INTL INCcl a | $137,260,000 | -8.8% | 2,546,564 | -15.5% | 3.07% | -26.8% |
BILI | Buy | BILIBILI INCspons ads rep z | $131,632,000 | +101.2% | 8,090,463 | +134.4% | 2.94% | +61.5% |
FGEN | Buy | FIBROGEN INC | $123,094,000 | +13.1% | 2,724,519 | +36.0% | 2.75% | -9.2% |
TSLA | New | TESLA INC | $116,329,000 | – | 520,580 | +100.0% | 2.60% | – |
MLCO | MELCO RESORT AND ENTMT LTDadr | $95,475,000 | -3.9% | 4,395,700 | 0.0% | 2.14% | -22.8% | |
ESGR | ENSTAR GROUP LIMITED | $94,719,000 | +0.2% | 543,487 | 0.0% | 2.12% | -19.6% | |
APLS | APELLIS PHARMACEUTICALS INC | $65,370,000 | +29.9% | 2,579,708 | 0.0% | 1.46% | +4.4% | |
SNAP | New | SNAP INCcl a | $63,862,000 | – | 4,465,885 | +100.0% | 1.43% | – |
BBIO | New | BRIDGEBIO PHARMA INC | $63,458,000 | – | 2,352,900 | +100.0% | 1.42% | – |
MYOK | MYOKARDIA INC | $48,936,000 | -3.6% | 975,987 | 0.0% | 1.09% | -22.6% | |
BEDU | BRIGHT SCHOLAR ED HLDGS LTDsponsored ads | $36,111,000 | -12.4% | 3,985,797 | 0.0% | 0.81% | -29.7% | |
MOMO | New | MOMO INCadr | $34,679,000 | – | 968,693 | +100.0% | 0.78% | – |
LN | LINE CORPsponsored adr | $33,986,000 | -20.1% | 1,207,763 | 0.0% | 0.76% | -35.9% | |
GTHX | G1 THERAPEUTICS INC | $29,110,000 | +84.7% | 949,431 | 0.0% | 0.65% | +48.3% | |
KNSA | KINIKSA PHARMACEUTICALS LTD | $24,858,000 | -25.0% | 1,835,888 | 0.0% | 0.56% | -39.8% | |
TME | TENCENT MUSIC ENTMT GROUPspon ads | $22,043,000 | -17.2% | 1,470,491 | 0.0% | 0.49% | -33.5% | |
GOSS | GOSSAMER BIO INC | $20,794,000 | +2.4% | 937,500 | 0.0% | 0.46% | -17.8% | |
ZM | New | ZOOM VIDEO COMMUNICATIONS INcl a | $19,978,000 | – | 225,000 | +100.0% | 0.45% | – |
MOGU | New | MOGU INCspon ads | $14,887,000 | – | 5,223,485 | +100.0% | 0.33% | – |
ARVN | ARVINAS INC | $13,744,000 | +49.0% | 625,000 | 0.0% | 0.31% | +19.5% | |
SOHU | SOHU COM LTDsponsored ads | $11,228,000 | -15.6% | 802,034 | 0.0% | 0.25% | -32.2% | |
RGNX | New | REGENXBIO INC | $10,582,000 | – | 206,000 | +100.0% | 0.24% | – |
AKRO | New | AKERO THERAPEUTICS INC | $8,139,000 | – | 425,000 | +100.0% | 0.18% | – |
EIDX | EIDOS THERAPEUTICS INC | $5,551,000 | +32.5% | 178,600 | 0.0% | 0.12% | +6.0% | |
RCUS | ARCUS BIOSCIENCES INC | $3,379,000 | -36.3% | 425,000 | 0.0% | 0.08% | -48.6% | |
BYND | New | BEYOND MEAT INC | $2,410,000 | – | 15,000 | +100.0% | 0.05% | – |
HOOK | New | HOOKIPA PHARMA INC | $1,923,000 | – | 285,714 | +100.0% | 0.04% | – |
NXTC | New | NEXTCURE INC | $1,124,000 | – | 75,000 | +100.0% | 0.02% | – |
CIH | New | CHINA INDEX HLDGS LTDspnsrd ads a | $1,065,000 | – | 300,000 | +100.0% | 0.02% | – |
SFUN | FANG HLDGS LTDadr | $932,000 | -54.0% | 1,500,000 | 0.0% | 0.02% | -62.5% | |
NEW | PUXIN LTDads | $792,000 | -9.4% | 126,145 | 0.0% | 0.02% | -25.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BEIGENE LTD | 20 | Q3 2023 | 26.0% |
JD.COM INC | 20 | Q3 2023 | 13.1% |
IQIYI INC | 20 | Q3 2023 | 12.3% |
MONDELEZ INTL INC | 20 | Q3 2023 | 5.9% |
KINIKSA PHARMACEUTICALS LTD | 20 | Q3 2023 | 1.6% |
SOHU COM LTD | 20 | Q3 2023 | 0.6% |
PINDUODUO INC | 19 | Q3 2023 | 16.1% |
GOSSAMER BIO INC | 19 | Q3 2023 | 2.3% |
BRIDGEBIO PHARMA INC | 18 | Q3 2023 | 3.4% |
MELCO RESORTS AND ENTMT LTD | 18 | Q1 2023 | 2.8% |
View HHLR ADVISORS, LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
I-Mab | June 30, 2023 | 15,891,211 | 8.3% |
BeiGene, Ltd. | February 14, 2023 | 147,043,058 | 10.9% |
Gossamer Bio, Inc. | February 14, 2023 | 4,974,041 | 5.3% |
On Holding AG | February 14, 2023 | 5,468,504 | 1.9% |
Root, Inc. | February 14, 2023 | 138,977 | 1.5% |
Yatsen Holding Ltd | February 14, 2023 | 300,560,602 | 19.1% |
iQIYI, Inc. | July 11, 2022 | 149,075,912 | 5.0% |
Apellis Pharmaceuticals, Inc. | February 14, 2022 | ? | ? |
Beam Therapeutics Inc. | February 14, 2022 | ? | ? |
Futu Holdings Ltd | February 14, 2022 | 2 | - |
View HHLR ADVISORS, LTD.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
4 | 2024-02-01 |
13F-HR | 2023-11-14 |
View HHLR ADVISORS, LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.